comparemela.com

Latest Breaking News On - Multidisciplinary head - Page 1 : comparemela.com

PDS Biotechnology Announces Details of Virtual KOL Event

PDS Biotechnology Announces Details of Virtual KOL Event
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

University-of-north-carolina
North-carolina
United-states
Boston
Massachusetts
New-york
Maryland
Baltimore
Dana-farber-cancer-institute
University-of-maryland
France
Saint-joseph

Naveris Announces New Data at ASTRO Multidisciplinary Head and Neck Cancers Symposium 2024

Naveris Announces New Data at ASTRO Multidisciplinary Head and Neck Cancers Symposium 2024
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Massachusetts
United-states
Waltham
North-carolina
Phoenix
Arizona
American
Barrym-berger
Megan-kernan
Meghant-turner
Adam-raben
Marshall-posner

ADA member spotlight: Dr Sue Ching-Yeoh and her collaborative career

ADA member spotlight: Dr Sue Ching-Yeoh and her collaborative career
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

Australia
Sydney
New-south-wales
Cooma
London
City-of
United-kingdom
Ching-yeoh
Chris-obrien-lifehouse
Oral-medicine-academy-of-australasia
Neck-cancer-multidisciplinary-team
Oral-medicine-department

Genmab A/S (GMAB) CEO Jan van de Winkel on Q1 2022 Results - Earning Call Transcript

Genmab A/S (GMAB) Q1 2022 Earning Conference Call May 11, 2022 12:00 PM ET Company Participants Jan van de Winkel - President and Chief Executive Officer Anthony Pagano - Chief Financial.

Arizona
United-states
Denmark
Danish
Wimal-kapadia
Morgan-stanley
Yaron-werber
Asthika-goonewardene
James-gordon
Peter-welford
Peter-virgil
Matthew-harrison

Seagen Reports First Quarter 2022 Financial Results

28.04.2022 - Seagen Inc. (Nasdaq:SGEN) reported financial results today for the first quarter ended March 31, 2022. The Company also highlighted PADCEV (enfortumab vedotin-ejfv), TUKYSA (tucatinib), ADCETRIS (brentuximab vedotin) and TIVDAK (tisotumab .

United-kingdom
United-states
Norway
Iceland
Japan
California
Liechtenstein
Canada
Russia
Washington
Switzerland
Seattle

vimarsana © 2020. All Rights Reserved.